Urethral duct invasion in female urethral melanoma  by Urban, Jennifer et al.
Human Pathology: Case Reports 6 (2016) 48–51
Contents lists available at ScienceDirect
Human Pathology: Case Reports
j ourna l homepage: http : / /www.humanpatho logycaserepor ts .comUrethral duct invasion in female urethral melanomaJennifer Urban a,1, Cheryl B. Bayart b,1, John A. Taylor c, Upendra Hegde d,
Faripour Forouhar e, Soheil S. Dadras e,f,⁎
a Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
b Department of Dermatology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
c Divsion of Urology, University of Connecticut (UCONN), Farmington, CT 06032, USA
d Department of Medicine, UCONN, Farmington, CT 06032, USA
e Department of Pathology, UCONN, Farmington, CT 06032, USA
f Departments of Dermatology, UCONN, Farmington, CT 06032, USA
a b s t r a c ta r t i c l e i n f o⁎ Corresponding author at: Department of Dermat
Farmington, CT, USA.
E-mail address: dadras@uchc.edu (S.S. Dadras).
1 These authors contribute equally.
http://dx.doi.org/10.1016/j.ehpc.2016.03.002
2214-3300/© 2016 The Authors. Published by Elsevier IArticle history:
Received 11 February 2016
Received in revised form 14 March 2016
Accepted 17 March 2016
Keywords:
Urethral melanoma
Urethral duct invasion
Invasion of von Brunn nests
Metastatic melanoma
Extramammary Paget's diseasePrimary melanoma of the genitourinary tract represents ≤1% of all melanomas and is a highly aggressive malig-
nancy, usually presenting at an advanced stage. Primary urethral melanomas are often amelanotic, leading to dif-
ﬁculties in early clinical diagnosis and biopsy delays. Herein,we present the clinical follow-up and histopathology
of two female patients with microscopic invasion of the urethral ducts, not illustrated by previous reports. This
ﬁnding, veriﬁed by appropriate immunohistochemical markers, can be a useful clue in diagnosing amelanotic
melanoma of the genitourinary tract. The pathology reporting for urethral melanoma should include the depth
of invasion, mitotic index, the status of resection margins, perineural invasion and lymphatic invasion since
theywill likely have a bearing on the tumor's biological behavior. Herein,we report two female patientswith ure-
thral melanoma exhibiting urethral duct invasion. Moreover, we discuss pertinent histopathological and immu-
nohistochemical features, along with oncogene mutational typing that may aid in conﬁrming the diagnosis and
identifying molecular target(s).
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Malignantmelanoma of the female urethra remains rare, accounting
for approximately 0.2% of primary melanomas [1], with the distal ure-
thra most often involved [2]. The average peak incidence is 65 years
[3]. Since the initial description by Reed in 1896 [4], more than 125
cases have been described in the English literature. Symptoms are
non-speciﬁc but may include the development of a urethral mass, peri-
neal pain, dysuria, increased urinary frequency, urinary incontinence,
hematuria or local bleeding [5]. The polypoid nature of these tumors
can mimic a urethral polyp, caruncle, or mucosal prolapse. Overall,
one ﬁfth of primary urethral melanomas are amelanotic [2], leading to
difﬁculties in early clinical diagnosis and biopsy delays. The presenta-
tion of advanced clinical stage in urethral melanomas usually correlates
with histologic evidence of vertical growth phase, analogous to nodular
sub-type of cutaneous melanoma [6]. Similar to their cutaneous
counterpart [7], urethral melanomas tend to metastasize at an early
stage via the superﬁcial lymphatics of the vagina and vulva, by theology, UCONN Health Center,
nc. This is an open access article undeep lymphatics to the inguinal lymph nodes, and occasionally
hematogenously to distal sites [8]. A recent meta-analysis of (73 arti-
cles) 112 female patients with primary urethral melanoma showed a
median survival of 16 months with a 5-year survival around 10% [3].
In a series of 9women and 6menwith urethralmelanoma, the distal
urethra was involved in all men and 8 women [2] with the following
histopathology: 1) conspicuousmelanin pigment in six cases; 2) polyp-
oid architecture with a mean diameter of 2.6 cm; 3) a vertical growth
phase was identiﬁed in all and a radial growth phase (intra-mucosal
component) in nine tumors; 4) depth of invasion ranged from 2 to
17 mm; and 5) a diverse vertical growth-phase pattern (e.g. diffuse,
nested, storiform or mixed). Cytological features include abundant eo-
sinophilic cytoplasm, large nuclei with prominent nucleoli and briskmi-
totic activity [2].
1.1. Patient 1
An 89 year-old female presented to UCONN urology department
with an amelanotic, hemorrhagic and polypoid urethralmass. A distinct
anterior urethral mass measuring 2.1 cm × 1.5 cm was identiﬁed with
uninvolved vaginal tissue. Patient underwent a partial urethrectomy
that included vaginal mucosa, followed by Temodar chemotherapy.
The urethrectomy specimen showed an ulcerated squamous mucosader the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Ulcerated, amelanotic nodule surrounded theurethralmeatus (arrowhead); andmelanoma in situ is identiﬁed in the adjacent squamous epithelium(arrow,A). Immunohistochem-
istry for Melan-A highlighted the invasion of melanoma cells in urothelium (arrowhead and inset), squamous epithelium (arrow) and lamina propria (B). Higher magniﬁcation of squa-
mous epithelium (area of arrow in A) showed a lack of pagetoid upward scatter but a distinct lentiginous, intra-mucosal component (C), highlighted byMelan-A immunohistochemistry
(D). Small, basaloidmelanoma cells tightly surrounded and invaded the urethral ducts (E), highlighted byMelan-A immunohistochemistry (F). Original magniﬁcation: A and B, 20×; C, D
and B inset, 100×; E, 200×; and F, 100×.
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rounding and compressing the urethral mucosa (Fig. 1A). The depth of
invasion was at least 14.5 mm; tumor cells were extensively transected
at the base (deep) resection margin, underestimating the true depth of
invasion. Theproliferation indexwas 5 mitoses/mm2, including atypical
mitotic ﬁgures. Melan-A immunostaining highlighted a submucosal
nodule, urethral (inset) and squamous epithelial invasion bymelanoma
cells (Fig. 1B–D). The tumor cells tightly condensed around stellate-
shaped urethral ducts and invaded them (Fig. 1E), highlighted by
Melan-A immunostaining (Fig. 1F). There were areas of lymphovascular
invasion, necrosis, hemorrhage and hemosiderin; however, no melanin
was identiﬁed (not shown). A variety of growth patterns were identiﬁed
in the specimen: lentiginous, nested, solid sheet and pseudopapillary (not
shown). Similar to Melan-A, S100 and HMB-45 immunostaining demon-
strated the junctional activity and inﬁltration of urotheliumbymelanoma
cells (not shown). Immunostaining for both estrogen and progesterone
receptors were negative (not shown).Eight months after the initial excision the patient developed
signiﬁcant and progressive shortness of breath. Positron emission to-
mography (PET) and computed tomography (CT) scans showed multi-
ple active lesions that had increased in number and size within the
bilateral lung parenchyma, thoracic spine vertebral body and posterior
segment of the right hepatic lobe. After 11 months, the patient died of
metastatic disease.
1.2. Patient 2
An 81-year-old woman presented to the UCONN Gynecology–
Oncology departmentwith a prior history of stage IIIB urethral melano-
madiagnosed 5 years ago. She initially presentedwith a small, enlarging
pigmented lesion of the distal urethra associated with intermittent
bloody vaginal discharge. Initially, the lesion was believed to represent
vaginal prolapse. A partial urethrectomy was performed and the speci-
men revealed fragments with ulcerated, atrophic urethral and
Fig. 2. Atrophic urothelium (arrowhead) was adjacent to large tumor nodules invading lamina propria (upper and lower right ﬁelds, A). Melanoma cells grew in nested and inﬁltrative
patterns (B) and were cytologically small, basaloid with scanty cytoplasm and hyperchromatic angulated nuclei (inset). C, Melanoma cells invaded urethral ducts (arrowheads) and
von Brunnnests (wavy arrows); foci ofmelanin (arrows)were seen throughout.Metastaticmelanoma replaced thenodal architecture (D) and cytologically resembled (inset) the primary
cells. The presence of amelanotic submucosal nodules in the anterior vaginal wall (E) with similar cytology (inset) deﬁned recurrence. One such nodule was readily pigmented (F) where
the tumor cells showed cytoplasmic melanin (inset). Numerous dermal melanoma nodules (G) were seen in the hemivulvectomy specimen where perineural (H) and lymphovascular
invasion (I) were identiﬁed. Original magniﬁcation: A, D, F and G, 20×; B and E, 40×; C, H and I, 200×; and B, D, E and F insets, 400×.
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and nested pattern of growth (Fig. 2A–B). The depth of invasion was
at least 10.5 mm, again underestimating the true depth of invasion.
The cytology of tumor cells showed small to medium-size basaloid
cells with scanty cytoplasm and hyperchromatic, angulated nuclei
(Fig. 2B inset). The tumor cells tightly condensed around urethral
ducts and invaded them, identiﬁed by a minute amount of melanin
(Fig. 2C). The tumor cells were strongly and diffusely positive for S-
100, HMB-45, Melanin-A and tyrosinase and negative for cytokeratincocktail, synaptophysin, chromogranin, lymphocyte common antigen,
desmin, myogenin, myoglobulin and CD99 (not shown).
In the 18 months following the excision the patient developed clin-
ically apparent bilateral inguinal lymphadenopathy that was corrobo-
rated by lymphadenopathy seen on CT scan. Complete left inguinal
lymph node dissection revealed metastatic melanoma with near com-
plete replacement of nodal architecture in 1 of 15 lymph nodes
(Fig. 2D), while right lymph node dissection showed metastatic mela-
noma to 1 of 14 lymph nodes with extranodal extension (not shown).
51J. Urban et al. / Human Pathology: Case Reports 6 (2016) 48–51Themetastatic melanoma cells had similar cytology to the primary cells
(Fig. 2B inset). Three years after diagnosis, the patient began
complaining of a foreign body sensation in the vagina. CT scanning con-
ﬁrmed a vaginal nodule and found a new 1.3 cm× 1.2 cm nodule in the
left upper lung lobe. Six cycles of chemotherapy with carboplatin, vin-
blastine and temozolomide led to complete resolution of the lung nod-
ule and at least a 66% decrease in the size of the anterior vaginal wall
nodule. The resected vaginal lesion showed an amelanotic submucosal
nodule with similar cytology (Fig. 2E inset) to the primary melanoma
cells. One focus was heavily pigmented (Fig. 2F) with cytoplasmic mel-
anin (inset). The patient remained asymptomatic after the completion
of chemotherapy, with negative CT/PET scans at follow-up until
26 months after surgery when she presented with ﬁve new, violaceous
papulonodules on the right superior and inferior labia majora and clito-
ral hood and clitoris, which were ﬁrm, mobile and non-tender, and
ranging from 0.2 to 1.6 cm in diameter. An anterior hemivulvectomy
showed numerous dermal nodules (Fig. 2G), demonstrating perineural
(Fig. 2H) and lymphovascular invasion (Fig. 2I). The vulvar tumor was
tested for BRAF and KIT mutations. V600E mutation was not detected
in the BRAF gene. No mutations were detected in exons 9, 11, 13, 17
and 18 of the KIT gene. Fifty-eight months after initial presentation,
the patient died from metastatic disease.2. Discussion
Tumors affecting the female urethra include squamous cell carcino-
ma (60%), transitional cell carcinoma (20%), adenocarcinoma (10%), un-
differentiated tumors and sarcomas (8%), melanoma (2%) [1]. The
histological differential diagnosis of a poorly differentiated, amelanotic
urethral neoplasm includes urethral melanoma and extramammary
Paget's disease especially when invasion of urethral ducts and/or von
Brunn nests are identiﬁed (Figs. 1E–F and 2C). This pattern of epithelial
invasion by tumor cells can mimic extramammary Paget's disease from
the vulva in women or the scrotum or penis in men. However, cytolog-
ically the tumor cells in Paget's disease usually have abundant vacuolated
cytoplasm and large vesicular nuclei; and tend to cluster at the tips of rete
ridges or above a preserved basal cell layer. In contrast, melanoma cells
tend to grow in a linear fashion, replacing the basal keratinocytes
(Fig. 1C–D). A panel of immunohistochemicalmarkers are essential to dis-
tinguish the two as the Paget cells are typically positive for CK7, CK8 and
carcinoembryonic antigen while negative for the usual melanocytic
markers (S100, MART-1/Melan-A, tyrosinase, MITF and SOX10).
The American Joint Commission on Cancer (AJCC) has detailed prog-
nostic parameters to be used for cutaneousmelanoma (such as depth of
invasion, ulceration andmitotic index) but unfortunately these have not
been shown to signiﬁcantly affect disease prognosis for genitourinary
melanoma, i.e. mucosal melanoma outside of head and neck. This dis-
crepancy may be due to the anatomic location and/or fragmented na-
ture of the specimen, making it difﬁcult to reproducibly assess thetrue depth or anatomic level of invasion. Nevertheless, the pathology
reporting for urethral melanoma should include the best-attempted
depth of invasion and mitotic index (number of mitoses per squared
millimeter), as well as the status of resection margins, perineural inva-
sion and lymphatic invasion. These are critical aspects of reporting
since they will likely have a more relevant bearing on the tumor's bio-
logical behavior. Immunostaining for D2-40 (podoplanin) can help
demonstrate lymphatic invasion in ambiguous cases [9].
Generally, primary urethral melanomas carry a worse prognosis
than their cutaneous counterparts, likely for the following reasons:
1) advanced stage, often presenting one decade later [10], 2) richly
vascularized anatomic location and 3) unique genetic mutational spec-
trum. In contrast to nodular cutaneous melanoma that exhibit BRAF
(43–68%), NRAS (12–31%) and ERK (78%) mutations, mucosal melano-
mas bear BRAF (3–11%), NRAS (5–15%) and KIT (15–39%) mutations
(reviewed in [11]). Targeting KIT by speciﬁc inhibitors such as Imatinib,
Sunitinib and Nilotinib has provided a novel treatment strategy for mu-
cosal melanomas (reviewed in [11]). To determine the eligibility of our
second patient to receive molecularly targeted therapy, the vulvar
tumor was tested for BRAF and KITmutations and the results were neg-
ative. Treatment for localized, stage I disease, is oftenwide local excision
and sentinel lymph node biopsy. The recurrence rate is high and has
been estimated to be about 69% [1]. Metastasis to the inguinal nodes
often occurs early in the course of disease with 50% of the cases already
exhibiting inguinal lymph node involvement at the time of diagnosis. In
addition, chemotherapy and immunotherapy are often used in combi-
nation with surgery; however, their beneﬁt remains uncertain [3].
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